Skip navigation

Refine by Type

Refine by Keyword

Results 1 - 10 of 17 for PAZOPANIB
  1. Pazopanib is used to treat advanced renal cell carcinoma (RCC, a type of cancer that begins in the cells of the kidneys) in adults. Pazopanib is in a class of medications called kinase ...
  2. Targeted Therapies for Kidney Cancer (American Cancer Society)  
    ... the intestines, heart problems, and slow wound healing. Pazopanib (Votrient ® ) Pazopanib is another drug that blocks several tyrosine kinases ...
  3. ... in clinical trials include sorafenib (Nexavar ® ), sunitinib (Sutent ® ), pazopanib (Votrient ® ), cabozantinib (Cometriq), motesanib (AMG 706), axitinib (Inlyta ® ), ... Some other TKIs, such as sunitinib, sorafenib, and pazopanib, are already approved to treat other types of ...
  4. Targeted Cancer Therapies From the National Institutes of Health (National Cancer Institute)  
    ... VEGF signaling, thereby inhibiting angiogenesis and cell proliferation. Pazopanib (Votrient®) is approved to treat patients with advanced renal cell carcinoma and advanced soft tissue sarcoma . Pazopanib is a small-molecule inhibitor of several tyrosine ...
  5. Angiogenesis Inhibitors From the National Institutes of Health (National Cancer Institute)  
    ... have antiangiogenic activity, including sorafenib ( Nexavar ®), sunitinib ( Sutent ®), pazopanib ( Votrient ®), and everolimus ( Afinitor ®). Sorafenib is approved for ... for both kidney cancer and neuroendocrine tumors, and pazopanib for kidney cancer. Researchers are exploring the use ...
  6. Cancer Drug Information From the National Institutes of Health (National Cancer Institute)  
    ... Hydrochloride Pamidronate Disodium Panitumumab Paraplat (Carboplatin) Paraplatin (Carboplatin) Pazopanib Hydrochloride Pegaspargase Peginterferon Alfa-2b PEG-Intron (Peginterferon ...
  7. ... or proteins, such as sorafenib (Nexavar), bevacizumab (Avastin), pazopanib (Votrient), and everolimus (Afinitor), are now being studied ...
  8. ... as sorafenib (Nexavar ® ), nilotinib (Tasigna ® ), dasatinib (Sprycel ® ), and pazopanib (Votrient ™ ), are already being used to treat other ...
  9. Kidney Cancer (Urology Care Foundation)  
    ... advanced kidney cancer including sorafenib (Nexavar), sunitinib (Sutent), pazopanib, bevacizumab, temsirolimus and everolimus. Recent studies show that ...
  10. ... against NPC, including bevacizumab (Avastin ® ), sorafenib (Nexavar ® ), and pazopanib (Votrient ® ). Immunotherapy NPC seems to be caused at ...
previous · 1 · 2 · next